Table 2 Rates of chronic medication prescriptions a. and prescriptions filled at community pharmacies over time
2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
Overall | |||||||||||
Rate of chronic medication prescriptions for diabetes (%)d. | 3.54% | 5.65% | 9.40% | 12.84% | 15.77% | 19.94% | 23.13% | 25.29% | 26.55% | 26.24% | |
Share of prescriptions filled at community pharmacies (%)e. | 3.67% | 5.52% | 8.38% | 10.40% | 14.20% | 16.68% | 19.37% | 23.46% | 28.14% | 31.30% | |
Share of reimbursed expenditures accounted by community pharmacies (%)f. | 3.36% | 4.97% | 7.11% | 9.30% | 13.71% | 16.23% | 19.51% | 24.48% | 29.22% | 32.35% | |
Subgroups by class | |||||||||||
Share of prescriptions filled at community pharmacies (%) e. | |||||||||||
Biguanides | 3.43% | 5.31% | 8.39% | 10.44% | 14.12% | 16.73% | 19.52% | 23.32% | 28.22% | 31.66% | |
Sulfonylureas | 4.01% | 6.22% | 9.59% | 11.80% | 15.58% | 17.96% | 20.17% | 24.06% | 28.42% | 31.29% | |
Alpha-glucosidase inhibitors | 0.94% | 1.98% | 3.17% | 6.14% | 10.27% | 13.38% | 17.06% | 22.02% | 27.48% | 30.95% | |
Thiazolidinediones | 1.21% | 2.93% | 4.66% | 6.81% | 11.23% | 13.67% | 18.18% | 23.91% | 29.23% | 32.00% | |
Dipeptidyl peptidase-4 inhibitors | N/A c. | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 24.89% | 30.32% | |
Othersb. | 1.30% | 1.51% | 3.40% | 5.30% | 8.87% | 11.99% | 15.25% | 20.12% | 25.42% | 28.59% | |
Share of reimbursed expenditures accounted by community pharmacies (%) f. | |||||||||||
Biguanides | 3.23% | 5.07% | 7.71% | 9.98% | 13.91% | 16.92% | 20.47% | 24.77% | 29.51% | 32.91% | |
Sulfonylureas | 3.85% | 6.24% | 9.49% | 12.06% | 16.61% | 18.85% | 21.13% | 25.26% | 29.73% | 32.80% | |
Alpha-glucosidase inhibitors | 0.75% | 1.67% | 2.78% | 5.46% | 9.47% | 12.72% | 16.47% | 21.77% | 27.63% | 31.36% | |
Thiazolidinediones | 1.12% | 2.93% | 4.29% | 6.56% | 11.18% | 13.76% | 18.62% | 24.88% | 30.28% | 33.23% | |
Dipeptidyl peptidase-4 inhibitors | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 25.81% | 31.13% | |
Othersb. | 1.28% | 1.38% | 2.99% | 5.11% | 8.71% | 11.88% | 15.38% | 20.97% | 26.41% | 29.80% | |